Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery

被引:4
作者
Singh, Vijai [1 ]
Somvanshi, Pallavi [1 ]
机构
[1] Bioinformat Ctr, Lucknow, Uttar Pradesh, India
关键词
Mycobacterium tuberculosis; Peptide deformylase; Docking; Phylogeny; Drugs;
D O I
10.2174/157018009789108286
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptide deformylase (PDF) is a ubiquitous bacterial metalloenzyme responsible to cleave the formyl group from nascent polypeptides, supporting in the maturation. It plays a vital role in the survival of bacterial cells which is conserved in the eubacteria and is considered to be an attractive target for developing new antibacterial agents. Homology modeling was employed for generation of 3-D structure of PDF of M. tuberculosis H37Rv and showed 92.5% amino acid in the allowed region of Ramachandran plot. PDF was used as target for a set of inhibitors with substantial structural differences. Docking results show that the BB-3497, BBS-54, Actinonin and BBS-02 bind with high affinity to enzyme active site. Phylogeny of PDF in M. tuberculosis H37Rv shows homology with other strains of pathogenic bacteria. These data validate PDF as a novel target for the design of a new generation of antimycobacterial agents.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [41] Peptide Deformylase (def) is essential in Mycobacterium smegmatis, but the essentiality is compensated by inactivation of methionine formylation
    Naor, Noga
    Gadot, Omer
    Meir, Michal
    Barkan, Daniel
    BMC MICROBIOLOGY, 2019, 19 (01)
  • [42] A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
    Deelder, Wouter
    Napier, Gary
    Campino, Susana
    Palla, Luigi
    Phelan, Jody
    Clark, Taane G.
    BMC GENOMICS, 2022, 23 (01)
  • [43] Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
    Sharma, Sandeep
    Sharma, Divakar
    Kalia, Nitin Pal
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [44] In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis
    Jagadeb, Manaswini
    Rath, Surya Narayan
    Sonawane, Avinash
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (13) : 3388 - 3398
  • [45] Identification of novel scaffolds targeting Mycobacterium tuberculosis
    Dal Molin, Michael
    Selchow, Petra
    Schaefle, Daniel
    Tschumi, Andreas
    Ryckmans, Thomas
    Laage-Witt, Stephan
    Sander, Peter
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (11): : 1601 - 1613
  • [46] Mechanisms of Mycobacterium tuberculosis Drug Resistance
    Shulgina, M. V.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2024, 39 (01) : 1 - 13
  • [47] Mechanisms of drug resistance in mycobacterium tuberculosis
    Wade, MM
    Zhang, Y
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 975 - 994
  • [48] Drug Resistance Mechanisms in Mycobacterium tuberculosis
    Palomino, Juan Carlos
    Martin, Anandi
    ANTIBIOTICS-BASEL, 2014, 3 (03): : 317 - 340
  • [49] Oxidative Phosphorylation-an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis
    Foo, Caroline Shi-Yan
    Pethe, Kevin
    Lupien, Andreanne
    APPLIED SCIENCES-BASEL, 2020, 10 (07):
  • [50] The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway
    Negi, Anjali
    Sharma, Rashmi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265